Rac limits TGF-β-induced VEGF synthesis in osteoblasts

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Transforming growth factor-β (TGF-β) is known to stimulate vascular endothelial growth factor (VEGF) synthesis.
• Previous studies implicated MAP kinases and SAPK/JNK pathways in this TGF-β-induced VEGF production in osteoblast-like cells.

Purpose of the Study:

• To investigate the role of Rac, a small GTPase, in the regulation of TGF-β-stimulated VEGF synthesis in MC3T3-E1 osteoblast-like cells.
• To elucidate the signaling pathways involved in Rac-mediated regulation of VEGF production.

Main Methods:

• Utilized MC3T3-E1 osteoblast-like cells.
• Administered TGF-β and specific inhibitors like NSC23766 (Rac inhibitor) and SIS3 (Smad3 inhibitor).
• Assessed VEGF release, mRNA expression, GTP-bound Rac levels, and phosphorylation of various signaling molecules (MAP kinases, Smad proteins) using knockdown and inhibitor approaches.

Main Results:

• TGF-β increased GTP-bound Rac levels, indicating Rac activation.
• Inhibition or knockdown of Rac enhanced TGF-β-induced VEGF synthesis and mRNA expression.
• Rac inhibition (NSC23766) specifically enhanced TGF-β-induced p38 MAP kinase phosphorylation, without affecting p44/p42 MAP kinase or SAPK/JNK.
• Rac knockdown also upregulated TGF-β-induced p38 MAP kinase phosphorylation.

Conclusions:

• Rac acts as a negative regulator in the TGF-β-stimulated VEGF synthesis pathway in osteoblasts.
• This negative regulation is mediated through the inhibition of p38 MAP kinase signaling.
• Findings reveal a novel mechanism controlling VEGF production in bone cells, with implications for bone biology and related disorders.